Cited 0 time in
Prognostic Factors for Gastric Cancer Patients with Synchronous Metastasis
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Kim, Hyun Il | - |
| dc.contributor.author | Ha, Tae Kyung | - |
| dc.contributor.author | Kwon, Sung Joon | - |
| dc.date.accessioned | 2022-07-16T22:23:46Z | - |
| dc.date.available | 2022-07-16T22:23:46Z | - |
| dc.date.issued | 2011-01 | - |
| dc.identifier.issn | 2233-7903 | - |
| dc.identifier.issn | 2093-0488 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/169293 | - |
| dc.description.abstract | Purpose: The prognosis for gastric cancer patients with distant metastasis is very poor. The purpose of this study was to evaluate the prognosis and survival for gastric cancer patients with synchronous metastasis. Methods: Among 2,083 gastric cancer patients who received surgery at the Department of Surgery, Hanyang University Hospital from 1992 to 2009, 164 patients revealed distant metastasis. However, 3 patients who died of postoperative complications were excluded. For the remaining patients, various clinicopathological factors were analyzed using univariate and multivariate survival analyses. Results: Systemic chemotherapy (SC), type of surgery, lymph node dissection, degree of peritoneal carcinomatosis (PC), presence of ascites and tumor location were significant prognostic factors. However, sex, age, number of metastatic sites and histologic classification were not significant prognostic factors. In multivariate analysis, the type of surgery, the SC and the degree of PC were independent prognostic factors. Survival benefit by SC was significant in single site metastasis. The significant survival difference between resection and non-resection groups was observed regardless of number of metastatic sites. Conclusion: In gastric cancer patients with metastasis, the favorable prognostic factors were type of surgery and SC in single metastasis. The gastrectomy improves the prognosis regardless of number of metastatic sites. However, a prospective randomized clinical trial is mandatory to attain more accurate information. (J Korean Slug Soc 2011;80:16-22) | - |
| dc.format.extent | 7 | - |
| dc.language | 한국어 | - |
| dc.language.iso | KOR | - |
| dc.title | Prognostic Factors for Gastric Cancer Patients with Synchronous Metastasis | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.4174/jkss.2011.80.1.16 | - |
| dc.identifier.scopusid | 2-s2.0-79958121331 | - |
| dc.identifier.wosid | 000286570400003 | - |
| dc.identifier.bibliographicCitation | Journal of the Korean Surgical Society, v.80, no.1, pp 16 - 22 | - |
| dc.citation.title | Journal of the Korean Surgical Society | - |
| dc.citation.volume | 80 | - |
| dc.citation.number | 1 | - |
| dc.citation.startPage | 16 | - |
| dc.citation.endPage | 22 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Surgery | - |
| dc.relation.journalWebOfScienceCategory | Surgery | - |
| dc.subject.keywordPlus | PALLIATIVE GASTRECTOMY | - |
| dc.subject.keywordPlus | LIVER METASTASIS | - |
| dc.subject.keywordPlus | RESECTION | - |
| dc.subject.keywordPlus | CHEMOTHERAPY | - |
| dc.subject.keywordPlus | DISSECTION | - |
| dc.subject.keywordPlus | SURVIVAL | - |
| dc.subject.keywordPlus | D2 | - |
| dc.subject.keywordAuthor | Gastric cancer | - |
| dc.subject.keywordAuthor | Metastasis | - |
| dc.subject.keywordAuthor | Prognostic factors | - |
| dc.identifier.url | https://astr.or.kr/DOIx.php?id=10.4174/jkss.2011.80.1.16 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
